[PSTX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -20.67%
YoY- 32.03%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
Revenue 28,142 10,343 1,435 0 0 0 -
PBT -24,274 -38,847 -58,057 -38,314 -28,784 -13,334 12.71%
Tax 1,337 1,359 1,096 826 1,312 1,471 -1.89%
NP -24,274 -40,206 -59,153 -38,314 -28,784 -13,334 12.71%
Tax Rate - - - - - - -
Total Cost 52,416 50,549 60,588 38,314 28,784 13,334 31.45%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
NP Margin -86.26 -388.73 -4,122.16 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
EPS -0.25 -0.47 -0.95 -0.62 -0.50 -0.34 -5.95%
EPS Diluted -0.25 -0.47 -0.95 -0.62 -0.50 -0.34 -5.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.